Skip to content

Gastrointestinal Anastomosis Using MonoPlus® Suture

Assessment of MonoPlus® Suture Material for Anastomosis in the Gastrointestinal Tract. A Prospective, Multi-centric, International, Single-arm, Observational Study in Daily Practice

Status
Withdrawn
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04811833
Acronym
GASTROMO
Enrollment
0
Registered
2021-03-23
Start date
2022-07-31
Completion date
2023-12-31
Last updated
2023-04-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colon Tumor, Digestive System Neoplasm, Gastrointestinal Neoplasms, Gastrointestinal Stromal Tumors, Rectum Tumor, Small Intestine Tumor, Stomach Tumor

Keywords

tumor disease, stomach tumor, small intestine tumor, colon tumor, rectum tumor, need for anastomosis

Brief summary

The primary aim of this study is to collect clinical data on the performance of MonoPlus® suture applied in routine clinical practice. Diverse parameters are to be used to assess the safety and efficacy of MonoPlus® suture for gastrointestinal anastomosis construction. This study has been designed to implement an action within the framework of a proactive Post Market Clinical Follow up (PMCF) activity.

Interventions

None listed

Sponsors

B.Braun Surgical SA
CollaboratorINDUSTRY
Aesculap AG
Lead SponsorINDUSTRY

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Adult patients undergoing an elective open or laparoscopic primary tumor resection within GI tract (stomach, small intestine, large intestine , colon and rectum. * Age ≥ 18 years * ASA ≤ III * Written informed consent

Exclusion criteria

* ASA ≥IV * Emergency operations * Peritonitis * Surgical interventions in the pancreas, oesophagus * Patients with traumatic perforations * Pregnant and/or breast-feeding women * Patients who had received chemotherapy within the last 4 weeks or radiotherapy on the treated region within the last 2 weeks * Patients who were receiving immunosuppressant therapy

Design outcomes

Primary

MeasureTime frameDescription
Comparison of anastomosis leakage rate at different timepoints in postoperative courseuntil 6 months after surgeryThe primary endpoint of this study is the anastomosis leakage rate until 6 months after surgery

Secondary

MeasureTime frameDescription
Comparison of the Peritonitis rate at different timepoints in postoperative courseat discharge (approximately 10 days after surgery), 1 month, and 6 months after surgeryComparison of the Peritonitis rate of the suture line at different postoperative examinations
Comparison of the Surgical Site infection rate at different timepoints in postoperative courseat discharge (approximately 10 days after surgery), 1 month, and 6 months after surgeryIncidence of postoperative surgical site infections, SSI (A1: Superficial incisional site infections and A2: Deep incisional surgical site infections) (efficacy parameter) Surgical Site Infection (SSI) is defined according to the definition of the US Centres for Disease Control and Prevention (CDC) at different postoperative examinations.
Comparison of bleeding at different timepoints in postoperative courseat discharge (approximately 10 days after surgery), 1 month, and 6 months after surgeryComparison of postoperative Bleeding rate at different postoperative examinations
Comparison of Abscess at different timepoints in postoperative courseat discharge (approximately 10 days after surgery), 1 month, and 6 months after surgeryComparison of postoperative Abscess rate at different postoperative examinations
Comparison of Postoperative Fistula at different timepoints in postoperative courseat discharge (approximately 10 days after surgery), 1 month, and 6 months after surgeryComparison of postoperative Fistula rate at different postoperative examinations
Comparison of Postoperative Perforation at different timepoints in postoperative courseat discharge (approximately 10 days after surgery), 1 month, and 6 months after surgeryComparison of postoperative Perforation rate at different postoperative examinations
Comparison of Postoperative Obstipation at different timepoints in postoperative courseat discharge (approximately 10 days after surgery), 1 month, and 6 months after surgeryComparison of postoperative Obstipation rate at different postoperative examinations
Comparison of Postoperative Stenosis at different timepoints in postoperative courseat discharge (approximately 10 days after surgery), 1 month, and 6 months after surgeryComparison of postoperative Stenosis rate at different postoperative examinations
Comparison of dehiscence rate of the suture line at different timepoints in postoperative courseat discharge (approximately 10 days after surgery), 1 month and 6 months after surgery.Comparison of the dehiscence rate of the suture line at different postoperative examinations
Comparison of Mortality rate at different timepoints in postoperative courseat discharge (approximately 10 days after surgery), 1 month, and 6 months after surgeryComparison of postoperative Mortality rate at different postoperative examinations
Comparison of Stoma rate at different timepoints in postoperative courseat discharge (approximately 10 days after surgery), 1 month, and 6 months after surgeryComparison of postoperative Stoma rate at different postoperative examinations
Length of the overall postoperative hospital stayuntil discharge (approximately 10 days postoperative)Number of days between date of surgery and date of discharge
Length of the postoperative stay in intensive care unituntil discharge (approximately 10 days postoperative)Number of days the patient has to stay in the intensive care unit after the intervention
Duration to perform the anastomosisintraoperativelyTime in Minutes the surgeon needs to perform the anastomosis
Course of Health Statusuntil 6 months postoperativeEQ-5D-5L is a standardized measure of health status developed by EuroQol Group in order to provide a simple, generic measure of health for clinical and economic appraisal. EQ-5D-5L is designed for self-completion by respondents and it takes only a few minutes to complete. Instructions to respondents are included in the questionnaire. EQ-5D-5L consists of 2 pages - descriptive system and the EQ visual Analogue scale (EQ-VAS). The descriptive system comprises 5 dimensions (mobility, self care, usual activities, pain/discomfort, anxiety/depression). Each dimension has 5 levels: no problems, slight problems, moderate problems, severe problems and extreme problems. The EQ VAS records the respondents self rated health on a 20 cm vertical , visual analogue scale with endpoints labelled the best health you can imagine and the worst health you can imagine
Satisfaction of the patient with the surgeryat discharge (approximately 10 days postoperative), 1 month, and 6 months after surgeryThis parameter will be noted using the Visual Analogue Scale (VAS) which state 0 at one end representing no pain and 100 at the opposite end representing maximal pain. The values are compared over postoperative period.
Assessment of suture material handling parametersintraoperativelyAssessment of the handling of the suture material intra-operatively using a questionnaire including different dimensions (knot security, tensile strength, knot run down, stiffness) with 5 evaluation levels (excellent, very good, good, satisfied, poor).
Comparison of Reoperation rate due to an anastomosis leakage at different timepoints in postoperative courseat discharge (approximately 10 days after surgery), 1 month, and 6 months after surgeryComparison of Reoperation rate due to an anastomosis leakage at different postoperative examinations

Countries

Spain

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026